| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
|
15,381 |
13,438 |
$716K |
| 93306 |
|
4,943 |
4,451 |
$322K |
| 93000 |
|
7,638 |
6,942 |
$64K |
| 99232 |
|
1,614 |
1,130 |
$50K |
| 78452 |
|
542 |
484 |
$37K |
| 99205 |
Prolong outpt/office vis |
119 |
95 |
$13K |
| 99213 |
|
281 |
244 |
$8K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
101 |
79 |
$8K |
| 93458 |
|
49 |
45 |
$7K |
| 93015 |
|
201 |
161 |
$7K |
| 99244 |
|
24 |
24 |
$4K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
871 |
585 |
$2K |
| 99406 |
|
160 |
141 |
$908.30 |
| 99443 |
|
18 |
13 |
$746.22 |
| 93296 |
|
45 |
41 |
$703.16 |
| 99223 |
Prolong inpt eval add15 m |
57 |
51 |
$671.09 |
| 93295 |
|
13 |
13 |
$504.01 |
| 93016 |
|
40 |
31 |
$298.67 |
| 93299 |
|
26 |
25 |
$287.23 |
| J2785 |
Injection, regadenoson, 0.1 mg |
20 |
13 |
$216.81 |
| 93297 |
|
25 |
25 |
$207.39 |
| 93018 |
|
40 |
31 |
$206.85 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
155 |
123 |
$49.41 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
12,186 |
11,128 |
$1.03 |
| 1160F |
|
682 |
599 |
$0.06 |
| 3078F |
|
369 |
322 |
$0.06 |
| 1159F |
|
459 |
400 |
$0.06 |
| 3074F |
|
409 |
372 |
$0.04 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
8,493 |
7,765 |
$0.00 |
| 1124F |
|
1,778 |
1,637 |
$0.00 |
| G9744 |
Patient not eligible due to active diagnosis of hypertension |
11,110 |
10,024 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
9,580 |
8,766 |
$0.00 |
| G8598 |
Aspirin or another antiplatelet therapy used |
1,373 |
1,304 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
746 |
684 |
$0.00 |
| 4004F |
|
823 |
775 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
3,297 |
3,107 |
$0.00 |
| G8938 |
Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible |
56 |
48 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
10,988 |
10,047 |
$0.00 |
| 1111F |
|
4,778 |
4,571 |
$0.00 |
| 1123F |
|
1,097 |
1,013 |
$0.00 |
| 3008F |
|
680 |
596 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
5,319 |
4,806 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
1,922 |
1,787 |
$0.00 |
| 1036F |
|
10,532 |
9,537 |
$0.00 |
| 3079F |
|
105 |
91 |
$0.00 |
| G9906 |
Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) |
37 |
28 |
$0.00 |
| 3075F |
|
32 |
28 |
$0.00 |
| G8967 |
Fda approved oral anticoagulant is prescribed |
89 |
82 |
$0.00 |
| 1034F |
|
62 |
54 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
78 |
65 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
30 |
26 |
$0.00 |
| G8428 |
Current list of medications not documented as obtained, updated, or reviewed by the eligible clinician, reason not given |
74 |
64 |
$0.00 |
| G8599 |
Aspirin or another antiplatelet therapy not used, reason not given |
13 |
13 |
$0.00 |